(Q39655893)

30 June 2019

title

Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL. (English)

1 reference

30 June 2019

0 references

1 reference

8

Steven A Rosenberg

1 reference

30 June 2019

author name string

Stephanie L Goff

1

1 reference

30 June 2019

Franz O Smith

2

1 reference

30 June 2019

Jacob A Klapper

3

1 reference

30 June 2019

Richard Sherry

4

1 reference

30 June 2019

John R Wunderlich

5

1 reference

30 June 2019

Seth M Steinberg

6

1 reference

30 June 2019

Donald White

7

1 reference

30 June 2019

Mark E Dudley

9

1 reference

30 June 2019

James C Yang

10

1 reference

30 June 2019

publication date

1 October 2010

1 reference

30 June 2019

published in

Journal of Immunotherapy

1 reference

30 June 2019

volume

33

1 reference

30 June 2019

issue

8

1 reference

30 June 2019

page(s)

840-847

1 reference

30 June 2019

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

cites work

1 reference

12 December 2020

Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.

1 reference

12 December 2020

Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines

1 reference

12 December 2020

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

12 December 2020

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions

1 reference

12 December 2020

Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes

1 reference

12 December 2020

Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR.

1 reference

12 December 2020

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

12 December 2020

Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes

1 reference

12 December 2020

Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines

1 reference

12 December 2020

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

1 reference

12 December 2020

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

12 December 2020

Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial c

1 reference

12 December 2020

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

12 December 2020

10.1097/CJI.0B013E3181F05B91

Identifiers

DOI

1 reference

30 June 2019

PMC publication ID

6322671

1 reference

30 June 2019

PubMed publication ID

20842052

1 reference

30 June 2019